IBDEI1XL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30848,2)
 ;;=^5063033
 ;;^UTILITY(U,$J,358.3,30849,0)
 ;;=N17.0^^123^1596^3
 ;;^UTILITY(U,$J,358.3,30849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30849,1,3,0)
 ;;=3^AKI w/ Tubular Necrosis
 ;;^UTILITY(U,$J,358.3,30849,1,4,0)
 ;;=4^N17.0
 ;;^UTILITY(U,$J,358.3,30849,2)
 ;;=^5015598
 ;;^UTILITY(U,$J,358.3,30850,0)
 ;;=N17.1^^123^1596^1
 ;;^UTILITY(U,$J,358.3,30850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30850,1,3,0)
 ;;=3^AKI w/ Acute Cortical Necrosis
 ;;^UTILITY(U,$J,358.3,30850,1,4,0)
 ;;=4^N17.1
 ;;^UTILITY(U,$J,358.3,30850,2)
 ;;=^5015599
 ;;^UTILITY(U,$J,358.3,30851,0)
 ;;=N17.2^^123^1596^2
 ;;^UTILITY(U,$J,358.3,30851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30851,1,3,0)
 ;;=3^AKI w/ Medullary Necrosis
 ;;^UTILITY(U,$J,358.3,30851,1,4,0)
 ;;=4^N17.2
 ;;^UTILITY(U,$J,358.3,30851,2)
 ;;=^5015600
 ;;^UTILITY(U,$J,358.3,30852,0)
 ;;=N10.^^123^1596^6
 ;;^UTILITY(U,$J,358.3,30852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30852,1,3,0)
 ;;=3^Acute Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,30852,1,4,0)
 ;;=4^N10.
 ;;^UTILITY(U,$J,358.3,30852,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,30853,0)
 ;;=N17.8^^123^1596^4
 ;;^UTILITY(U,$J,358.3,30853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30853,1,3,0)
 ;;=3^AKI,Other
 ;;^UTILITY(U,$J,358.3,30853,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,30853,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,30854,0)
 ;;=N17.9^^123^1596^5
 ;;^UTILITY(U,$J,358.3,30854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30854,1,3,0)
 ;;=3^AKI,Unspec
 ;;^UTILITY(U,$J,358.3,30854,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,30854,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,30855,0)
 ;;=R39.2^^123^1596^15
 ;;^UTILITY(U,$J,358.3,30855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30855,1,3,0)
 ;;=3^Pre-Renal Uremia
 ;;^UTILITY(U,$J,358.3,30855,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,30855,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,30856,0)
 ;;=N13.9^^123^1596^14
 ;;^UTILITY(U,$J,358.3,30856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30856,1,3,0)
 ;;=3^Obstructive and Reflux Uropathy,Unspec
 ;;^UTILITY(U,$J,358.3,30856,1,4,0)
 ;;=4^N13.9
 ;;^UTILITY(U,$J,358.3,30856,2)
 ;;=^5015589
 ;;^UTILITY(U,$J,358.3,30857,0)
 ;;=N13.1^^123^1596^11
 ;;^UTILITY(U,$J,358.3,30857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30857,1,3,0)
 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
 ;;^UTILITY(U,$J,358.3,30857,1,4,0)
 ;;=4^N13.1
 ;;^UTILITY(U,$J,358.3,30857,2)
 ;;=^5015576
 ;;^UTILITY(U,$J,358.3,30858,0)
 ;;=N13.2^^123^1596^10
 ;;^UTILITY(U,$J,358.3,30858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30858,1,3,0)
 ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction
 ;;^UTILITY(U,$J,358.3,30858,1,4,0)
 ;;=4^N13.2
 ;;^UTILITY(U,$J,358.3,30858,2)
 ;;=^5015577
 ;;^UTILITY(U,$J,358.3,30859,0)
 ;;=N13.30^^123^1596^13
 ;;^UTILITY(U,$J,358.3,30859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30859,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,30859,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,30859,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,30860,0)
 ;;=N13.39^^123^1596^12
 ;;^UTILITY(U,$J,358.3,30860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30860,1,3,0)
 ;;=3^Hydronephrosis,Other
 ;;^UTILITY(U,$J,358.3,30860,1,4,0)
 ;;=4^N13.39
 ;;^UTILITY(U,$J,358.3,30860,2)
 ;;=^5015579
 ;;^UTILITY(U,$J,358.3,30861,0)
 ;;=R33.9^^123^1596^16
 ;;^UTILITY(U,$J,358.3,30861,1,0)
 ;;=^358.31IA^4^2
